Urinary catecholamines and metabolites in the immediate postoperative period following major surgery by Syed, A. A. et al.
SHORT REPORT
Urinary catecholamines and metabolites in the immediate
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Background: Induction of anaesthesia can precipitate cate-
cholamine release from an undiscovered pheochromocytoma
and induce a hypertensive crisis. However, it is assumed that
catecholamine and metabolite values resulting from the
effects of surgery per se in the early postoperative period
would overlap with the values generated by a tumour, and it
is not known how soon after biochemical investigations can
be carried out.
Aim: To study patterns of urinary catecholamine excretion
and the feasibility of biochemical screening for phaeochro-
mocytomas in the immediate postoperative period in
otherwise healthy subjects undergoing a single type of major
surgical procedure.
Methods: Catecholamines and metabolites were measured
for each mole of creatinine in single voided urine on one
preoperative and four postoperative days in five subjects
who underwent elective coronary artery bypass graft surgery
with an uncomplicated postoperative course. Reference
ranges were established from 33 healthy normotensive
volunteers.
Results: Excretion of adrenaline, noradrenaline, dopamine,
vanillylmandelic acid, and metadrenaline was within normal
limits. Normetadrenaline excretion was mildly raised in four
patients, but did not exceed 1.5 times the upper reference
limit, and returned to normality by the fourth postoperative
day.
Conclusion: It is feasible to perform simple urinary screening
for possible phaeochromocytoma in the immediate post-
operative period.
A
lthough phaeochromocytomas are rare, accounting for
0.1–1% of all cases of hypertension,1 occasionally,
unsuspected cases present with a hypertensive episode
during the induction of anaesthesia or surgery for unrelated
conditions.2 3 It would be reasonable, therefore, to screen for
catecholamine secreting tumours in surgical patients in
whom hypertension is first seen or becomes difficult to
control perioperatively. However, a very high false positive
rate in the early postoperative period resulting from the
effects of surgery per se is generally expected, and it is not
known how soon after surgery biochemical screening tests
can be reliably performed. The aim of our study was to
determine patterns of urinary catecholamine excretion and
the feasibility of biochemical screening for phaeochromocy-
tomas in the immediate postoperative period in otherwise
healthy subjects undergoing a single type of major surgical
procedure.
MATERIALS AND METHODS
We prospectively studied five subjects (four men) ranging in
age from 41 to 75 (mean, 54.8) years who underwent elective
coronary artery bypass graft surgery. None of them was
administered catecholamines as part of their management
and all had a routine postoperative recovery. For the purpose
of this preliminary study, we monitored urinary catechola-
mine and metabolite excretion for each mole of creatinine
using ‘‘spot’’ urine specimens, because this eliminates
sampling errors of timed collections, and has a sensitivity
of 97–100% and a specificity of 98–100%.4–6 Midday self
voided or fresh catheter urine was obtained on one
preoperative (day 0) and four postoperative days (days 1–
4). Thirty three healthy volunteers (14 men, 10 women, nine
undeclared sex), ranging in age from 22 to 55 (mean, 35.7)
years, with no history of hypertension, served as controls for
the determination of reference ranges, and 1.5 times the
upper limit was regarded as the threshold of significance.7
Samples were acidified with concentrated hydrochloric acid
to pH , 4.0 immediately (within one hour) after collection.
Adrenaline (A), noradrenaline (NA), dopamine (DA), meta-
drenaline (MA), and normetadrenaline (NMA) were mea-
sured using high performance liquid chromatography
incorporating sample clean up with automated sample trace
enrichment of dialysate coupled with electrochemical detec-
tion,8 and vanillylmandelic acid (VMA) by gas chromato-
graphy of trimethyl silyl derivatives (Pisano reaction).9
Creatinine was measured by a kinetic colorimetric assay
(Jaffe´ reaction).10 A single determination was performed for
all analytes. Our study conformed with the ethical principles
of the Declaration of Helsinki (Fifth Amendment) and
participants gave their consent.
RESULTS
A (reference range, 1–20 nmol/mol creatinine), NA (refer-
ence range, 4–185 nmol/mol creatinine), DA (reference
range, 83–643 nmol/mol creatinine), MA (reference range,
9–681 mmol/mol creatinine), and VMA (reference range,
0.42–7.27 mmol/mol creatinine) remained well within their
respective reference ranges on all days in all subjects (fig 1).
Mild increases in NMA (reference range, 5–242 mmol/mol
creatinine), not exceeding 1.5 times the upper reference limit,
were seen postoperatively in four patients (patients 1–4) on
days 1–3, returning to normality by day 4.
DISCUSSION
We report that catecholamine and metabolite excretion is not
significantly increased after major surgery using elective open
chest coronary revascularisation as an example. We suggest
that this is, at least in part, explained by good perioperative
anxiolysis and pain relief achieved by modern anaesthetic
techniques. This finding reflects a previous report that
circulating plasma catecholamine concentrations do not
increase significantly above preanaesthetic values in patients
Abbreviations: A, adrenaline; DA, dopamine; MA, metadrenaline;
NA, noradrenaline; NMA, normetadrenaline; VMA, vanillylmandelic
acid
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undergoing cardiac surgery.11 However, no conclusions could
be drawn from urinary measurements in that study because
analysis was complicated by the finding of a positive
correlation between catecholamine excretion and urine flow
rate.
Raised concentrations of NA compared with the hyperten-
sive reference range are often seen in patients with
hypertension or myocardial infarction treated with
b blockers.12 13 The modest rise in NMA excretion in our
study could be a reflection of a similarly raised noradrenergic
tone, although NA excretion itself was not increased, and
may indicate the need for an ‘‘adjusted normal range’’ for
postoperative patients.
‘‘The main advantage of urinary screening in this situation
is that it facilitates rapid elimination of phaeochromocy-
toma from the differential diagnosis’’
We acknowledge that urinary screening in surgical patients
who experience a stormy perioperative course may be
associated with a poor positive predictive value. However,
given its very high negative predictive value (100%),14 the
main advantage of urinary screening in this situation is
that it facilitates rapid elimination of phaeochromocytoma
from the differential diagnosis. Although the small
number of subjects, who all had a routine postoperative
course, limits the applicability of our study, it has
established that the general expectation of false positive
results in nearly all surgical patients in the immediate
postoperative period is erroneous. In conclusion, we propose
that it is feasible to investigate patients for possible
phaeochromocytoma in the immediate postoperative period
by simple urinary screening, but a larger study encompassing
a wider spectrum of surgical and anaesthetic procedures is
required.
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Figure 1 Catecholamines and
metabolites expressed for each mole of
creatinine in single voided urine
specimens on one preoperative (day 0)
and four postoperative (days 1–4) days
in five patients undergoing coronary
artery bypass graft surgery. (A)
Adrenaline, (B) noradrenaline, (C)
dopamine, (D) vanillylmandelic acid,
(E) metadrenaline, (F)
normetadrenaline (NMA). The solid
horizontal lines mark the upper limit of
the reference range and the broken
horizontal lines (NMA) mark 1.5 times
the upper limit. Closed circles, patient
1; open squares, patient 2; open
triangles, patient 3; closed squares,
patient 4; closed triangles, patient 5;
open circles, mean.
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CORRESPONDENCE
If you have a burning desire to respond to a
paper published in the Journal of Clinical
Pathology, why not make use of our ‘‘rapid
response’’ option?
Log on to our website (www.jclinpath.
com), find the paper that interests you, and
send your response via email by clicking on
the ‘‘eLetters’’ option in the box at the top
right hand corner.
Providing it isn’t libellous or obscene, it
will be posted within seven days. You can
retrieve it by clicking on ‘‘read eletters’’ on
our homepage.
The editors will decide as before whether
to also publish it in a future paper issue.
Cancer stem cell theory:
pathologists’ considerations and
ruminations about wasting time
and wrong evaluations
The genomic revolution has changed the role
of the pathologist. In daily practice, our work
is no longer limited to reaching a correct
diagnosis and we are asked to answer
questions about the patient’s prognosis and
treatment options through the evaluation of
selected molecular targets (such as erbB2
for breast cancer) in tumour specimens.
Thus, we have acquired a major role in the
translation of novel gene findings from
experimental model systems to their clinical
application.
There is overwhelming evidence that only a
subset of cells within a tumour clone,
referred to as cancer stem cells, are tumori-
genic and possess the metastatic phenotype.1
The recent identification of human breast
cancer initiating cells by Al-Hajj and collea-
gues2 provided a major step forward in this
field. With this knowledge, the stem cell
compartment should represent the selected
target for tumour eradication.
As pathologists we would like to share
some considerations and ruminations about
this scenario.
Currently, tissue microarray analysis gen-
erates gene profiles capable of differentiating
tumours with different biological beha-
viours.3 However, this screening method is
conducted on heterogeneous tumour tissue
samples containing a mixture of non-neo-
plastic cells, non-tumorigenic cancer cells,
and cancer stem cells. Similarly, until now,
we have evaluated the immunohistochemical
expression of a molecular marker in the bulk
of the tumour, considering it as relatively
homogeneous.
What is the clinical relevance of these
results? Although new therapeutic appro-
aches based on these studies have modified
the prognosis of some neoplasms,4 conflicting
results are still seen with many other
tumours.5 We should start to feel worried
about the value of the information retrieved
from this type of tumour analysis.
The few cancer stem cells and the large
number of cells constituting the tumour are
morphologically similar but functionally het-
erogeneous. It is likely that we are still
evaluating the main population of tumour
cells, which are not cancer stem cells, and are
thus probably wasting time and loosing
essential treatment information. It is unlikely
that gene expression profiles obtained using
the currently available methods reflect those
of the tumour stem cell population, which
forms only 0.1–2% of the whole tissue
sample.1 2 6
The cancer stem cell hypothesis has started
a new era in cancer research. Tumours
contain functionally different subpopulations
of cells. However, unique gene expression
profiles are generated by current methods of
evaluation. Probably, when the isolation and
molecular characterisation of cancer stem
cells from primary tissue becomes possible,
the role of pathologists will change again.
Collaboration between researchers and
pathologists will be more widely practised
and we will be able to rise to the next
challenge; namely, assessing the prognosis of
a patient from only one of 5000 tumour cells
in a tissue sample.
P Nuciforo
Fimo-Firc Institute of Molecular Pathology, Via
Adamello 16, Milano 20139, Italy;
nuciforo@ifom-firc.it
F Fraggetta
Azienda Ospedaliera Cannizzaro, Via Messina, 829,
Catania 95126, Italy
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Public opinion on the use of tissue
samples
I read with interest and increasing concern
the paper by Goodson and Vernon,1 ‘‘A study
of public opinion on the use of tissue samples
from living subjects for clinical research’’. The
paper demonstrates that the use of a vaguely
worded and ambiguous questionnaire leads
to misleading results. A few of the problems
with the questions may be taken individually:
(1) ‘‘Would you be happy for pieces of any
of the following body tissues or organs
to be used in clinical research? (Eyes,
lung, heart, tissue from head and neck,
embryo, brain, ovary, testes, bone, and
breast.)’’
The question could refer to postmortem
tissue and the choice of organs is (as the
authors confess) deliberately ‘‘emotional’’,
with no insight into every day pathological
services. Heart, brain, and eyes are not
exactly common surgical specimens, whereas
embryos are subject to special guidelines.
Surely, this question is almost designed to
make the patient believe it refers to post-
mortem organs? The use of subjective words
such as ‘‘happy’’ is extremely unhelpful. ‘‘Are
you happy to vote Labour?’’ would not, for
example, be acceptable in a comparable
political survey!
(2) ‘‘What kind of research would you be
happy for your tissues to be used for?
(Cancer research, testing medicines,
genetic cloning, general knowledge of
body tissues, genetic research for diag-
nosis or treatment of, for example,
Down’s syndrome.)’’
Again scientific imprecision exists, because
the writers of the questionnaire appear not
to understand that these fields are interde-
pendent. In particular, the lack of public
understanding of cloning has caused them to
reject this field, with no idea that this may
include tissue culture or polymerase chain
reaction.
(3) ‘‘Would you want to be informed if your
tissues were to be stored beyond the time
required for diagnosis?’’
This question seems to show no knowledge
of the necessity for longterm storage of
samples after diagnosis. Tissue retention for
medicolegal, audit, clinical governance, and
comparison with later samples has been
ignored. No explanation has been given to
the patients of why this is in their best
interests.
(4) ‘‘Would you be happy to give consent for
a child’s tissues to be used for scientific
research?’’
Apart from the obvious flaw that it has not
been stated whose child is being talked
about, again the question appears almost
deliberately ambiguous and could be taken to
refer to postmortem tissue. Apparently, the
designers of the questionnaire are interested
in ‘‘scientific research’’ on children’s tissues,
whereas in adults in question 1 it is only
‘‘clinical research’’.
(5) ‘‘Would you be happy to give consent for
your tissues to be used to teach medical
students?’’
The word happy is used again, in addition
to a lack of explanation of how the tissues
are ‘‘used’’, and the vital role of histology in
teaching medical students and pathology
trainees.
I suggest to the authors that their survey,
in contrast to all other studies, shows that
patients were unwilling to donate their
tissues because they were presented with a
poorly designed, misleading survey.
D M Berney
Department of Pathology, St Bartholomew’s Hospital,
West Smithfield, London EC1A 7BE, UK;
danberney@hotmail.com
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Authors’ response
We are grateful for the opportunity to
respond to Dr Berney’s letter. The question-
naire used in our study was piloted on a
similar group of respondents. The patient
information leaflet and consent form given
and explained before completion of the
questionnaire made it clear that we were
only concerned with tissue donated by living
subjects for research and did not refer to the
use of postmortem specimens or tissue or
organs for transplantation. In addition, all
respondents were given the opportunity to
ask questions before completing the ques-
tionnaire if they were unsure of the meaning
of any questions.
We imagine that many of the research
fields are interdependent, although the gen-
eral public may not be aware of this. Our
study did not attempt to explain why res-
pondents answered questions in any particu-
lar way, but it shows that people may or may
not be willing to donate different types of
tissue for different types of research. This
may be because of a lack of understanding
of the clinical and laboratory techniques used
in research, but we have not attempted to
prove this in our study.
We agree that no explanation was given to
respondents (who were not patients) about
the benefits of retention of tissue samples;
this would have biased the response.
Dr Berney says that our question surround-
ing consenting for donation of a child’s tissue
for research is flawed because it does not
explain whose child we are discussing. Our
pilot study demonstrated that the phrase
‘‘your child’’ eliminated responses from
childless adults, adults with children over
16 years of age who were able to consent for
themselves, and individuals who had chil-
dren, but for various reasons were no longer
the guardians of such children. The question
merely attempted to identify whether or not
there was some reluctance by adults to
consent for children.
Our research showed a snap shot of public
attitudes to tissue donation from living sub-
jects for clinical research and offers no more
than an indicator of public attitude, and like
most research requires further qualification.
We are grateful to Dr Berney for his com-
ments because they open up the debate on
whether the public accepts tissue donation
for research purposes. To restore public
confidence in the medical profession and
research in general, it is crucial for the pro-
fession to take account of public perceptions
and to understand the nature of the explana-
tions that are required.
M L Goodson, B G Vernon
School of Population and Health Science, University of
Newcastle, Newcastle upon Tyne, NE2 4HH;
M.L.Goodson@ncl.ac.uk
Limitations of the Wilcoxon
matched pairs signed ranks test
for comparison studies
We read the short report by Ellis et al with
interest.1 However, we are unsure whether
they have adequately proved that no signifi-
cant difference was detected between the
two outlined storage methods.
The hypothesis evaluated with the
Wilcoxon matched pairs signed ranks test is
whether or not the median of the difference
scores equals zero. Let us consider the
situation of x measurements tending to
exceed y measurements in the low range
and vice versa in the high range, with similar
values in the mid range. Such results may
have a median of the difference scores of
approximately zero; that is, there might be no
significant differences by the Wilcoxon
matched pairs signed ranks test, although
there would be differences by linear regres-
sion (Deming or Passing-Bablok) and/or
difference plots.
However, this short report1 lacks both a
regression equation (proportional and con-
stant error) and difference plots. Therefore,
we believe that although the IgG anti-rubella
activity in frozen serum stored in primary gel
separation tubes may not be significantly
different from that stored frozen in secondary
tubes, this study did not sufficiently prove
this. We recommend, in line with others,2
that difference plots3 are used for such
comparative studies and that such studies
are put into a clinical context.3 4
P J Twomey
Department of Clinical Biochemistry, The Ipswich
Hospital, Heath Road, Ipswich IP4 5PD, UK;
taptwomey@aol.com
A Viljoen
Department of Clinical Biochemistry, Royal Infirmary
of Edinburgh, Room S6114 Level 2, 51 Little France
Crescent, Edinburgh EH16 4SA, UK
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Basic Pathology: An Introduction to
the Mechanisms of Disease
Lakhani S R, Dilly S A, Finlayson C J, et al.
(£22.99.) Arnold, 2003. ISBN 0340810017.
With the new ‘‘integrated’’ undergraduate
medical curriculum being adopted by medical
schools in many countries, there is an ever
increasing need for an appropriate basic
pathology textbook. The authors have pro-
duced a book which is based on the principles
and objectives of the integrated curriculum.
Consequently, it is an ideal basic pathology
textbook for students in the integrated
medical curriculum.
The book has a novel approach to basic
pathology, which is different from the
standard basic pathology textbooks. There
are four parts: ‘‘Introduction—what is a
BOOK REVIEWS
disease?’’, ‘‘Defence against disease’’,
‘‘Circulatory disorders’’, and ‘‘Disorders of
cell growth’’. Each part consists of a varia-
ble number of chapters containing several
unique learning aids.
The material is presented in a format
that is easy to read and can be read at
leisure. In accordance with the integrated
curriculum, some material is presented by
using clinical cases—for example, myocar-
dial infarction, breast lump, and prostatic
hyperplasia, among others. Innovative addi-
tions are the excellent cartoons, selected
‘‘key facts’’, ‘‘dictionary box’’, and ‘‘small
print’’. The cartoons are well illustrated,
extremely apt, and informative. There is
also a selection of relevant tables that
complement the text. The inclusion of
appropriate colour diagrams, photomicro-
graphs, and macroscopic pathology images
aids the text. Clinicopathological case stu-
dies are used as a tool to facilitate the
integration of pathology with clinical medi-
cine. At the end of each part, there is a
selection of questions covering core material
with answers and cross references.
There are six colour coded theme maps that
cover the four main pathology disciplines—
histopathology, haematology, immunology,
and microbiology—and two additional over-
view themes—science and disease and
patient and disease.
The authors have produced a remarkable
book, which deals with a difficult but
important subject in a user friendly manner.
The book ought to be prescribed reading for
undergraduate students in the new inte-
grated medical curriculum.
D Govender
The Cytology of Soft Tissue Tumours
Akerman M, Domanski H A. (J110.00.)
Karger, 2003. ISBN 3 8055 759 7.
A˚kerman’s and Domanski’s text The Cytology
of Soft Tissue Tumours from the Monographs in
Clinical Cytology series is a beautifully illu-
strated, well referenced and written treatise
on the interpretation of fine needle aspira-
tions (FNAs) of these lesions. The text starts
with a brief overview of the FNA of soft tissue
tumours including accuracy, pitfalls, compli-
cations, and a discussion of the aspiration
technique itself, with application of ancillary
studies. This is followed by a concise review
of the specific entities following standard
histogenetic organisation. With each major
entity, the salient cytological features and
differential diagnostic considerations are
clearly listed, with comments on the potential
pitfalls admixed with helpful hints, providing
a practical approach to the diagnosis of the
lesions. The final chapter summarises in
tabular form the salient diagnostic features
and results of ancillary studies of the various
entities in groupings based on a pattern recog-
nition approach. Illustrations abound and
include air dried May-Gru¨nwald-Giemsa, in
addition to alcohol fixed haematoxylin and
eosin or occasionally Papanicolaou stained
cytological preparations. Little criticism of
this text can be found and there is no
question that this book should be in the
library of those interpreting FNAs of soft
tissue lesions.
S Boerner
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Practical Pulmonary Pathology
27–30 July, 2004, Brompton Hospital,
London, UK
Further details: Professor B Corrin,
Brompton Hospital, London SW3 6NP, UK.
(Tel: +44 (0)20 7351 8420; Fax: +44 (0)20
7351 8293; Email: b.corrin@ic.ac.uk)
ACP Management Course for
Pathologists, 2004
8–10 September 2004, Hardwick Hall Hotel,
Sedgefield, County Durham, UK
Further details: V Wood, ACP Central Office,
189DykeRoad,Hove, East SussexBN31TL,UK.
(Tel: +44 (0) 1273 775700; Fax: +44 (0) 1273
773303; Email: Jacqui@pathologists.org.uk)
CORRECTIONS
MUC1 and MUC2 in pancreatic neopla-
sia. E Levi, D S Klimstra, N V Adsay,
A Andrea, O Basturk. J Clin Pathol 2004;
57:456–62. The order of the authors should
be E Levi, D S Klimstra, A Andrea, O Basturk,
N V Adsay.
Urinary catecholamines and metabo-
lites in the immediate postoperative per-
iod following major surgery. Dr A A Syed,
H A Wheatley, M N Badminton, et al.
J Clin Pathol 2004;57:548–50. The first
author’s name should be A A Syed.
Focal nodular hyperplasia with conco-
mitant hepatocellular carcinoma: a case
report and clonal analysis. S-H Zhang,
W-M Cong, M-C Wu. J Clin Pathol 2004;
57:556–9. The image shown in fig 2 should
have been fig 3 and vice versa.
Combined Adult and Congenital
Cardiovascular Pathology Course
8–10 November 2004, Imperial School of
Medicine, National Heart and Lung
Institute, London, UK
Further details: Short Course Office,
National Heart and Lung Institute,
Dovehouse Street, London SW3 6LY, UK.
(Tel: +44 (0)20 7351 8172; Fax: +44 (0)20
7351 8246; Email: shourtcourse.NHLI@
IC.AC.UK)
Asian Pacific Association for Study of
the Liver Biennial Conference
11–15 December 2004, New Delhi, India
Further details: Dr V Malhotra (General
Secretary) or Dr P Sakhuja (Treasurer
and Pathology Coordinator), Room 325,
Academic Block, Department of Pathology,
GB Pant Hospital, New Delhi 110002,
India. (Tel: +91 11 23237455; Email:
welcome@apaslindia2004.com; Website:
www.apaslindia2004.com)
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